Having committed $150 million to life sciences resources in the US in 2019, DHL Supply Chain is upping its ante with a new round of investment, totaling $70 million. Expansions are planned at Las Vegas, Memphis and Indianapolis, plus two other undisclosed locations; total 2-8°C storage capacity is rising from 12,000 pallets to 15,000, and overall storage capacity is rising by 1 million sq. ft. Additionally, the company is investing in more automation and IT, including expanded e-commerce capabilities and robotic devices on the warehouse floor.
One of the drivers of the current round of expansion, says David Kopstein, VP of Life Sciences & Healthcare, DHL Supply Chain North America, is that manufacturers are expanding their inventories of both ingredients and finished product, necessitating more storage capacity at logistics providers. DHL Life Sciences includes pharma, med devices and OTC products; recently the company also announced a 10-year relationship with Siemens Healthineeers, providers of medical imaging equipment, diagnostics and other products, for sales and service.